Odds of US hantavirus case dip as cruise monitoring fails to yield positive labs
· flowframe Pulse
The clock is ticking on a high-stakes health bet. Polymarket traders are recalculating the odds of a domestic hantavirus infection as the May 15 deadline looms. It's a frantic race between clinical testing lag and the market's expiration. This doesn't leave much room for error or the usual weekend reporting delays.
Bettors are reacting to a CDC Health Alert Network advisory following a deadly outbreak of the Andes strain aboard the cruise ship MV Hondius. While the agency is monitoring repatriated American passengers in a specialized Nebraska medical facility, no laboratory-confirmed cases have surfaced on U.S. soil. Health departments in Arizona and California are also tracking travelers who disembarked early. However, the CDC maintains that broad spread remains extremely unlikely. The lack of a confirmed lab result is forcing a reality check.
The contract just drifted from 79¢ to 70¢ as the window for a confirmed report narrows to just three days. That's a sharp pullback for a market with $0.5M of volume. It means the market is now pricing roughly a 70% chance of a hit. Earlier optimism is giving way to the realization that official confirmation often takes days to process.
Watch for any emergency update from the CDC's surveillance system or a press release from the Nebraska Department of Health and Human Services. If the current 72-hour re-testing window for those cruise ship returnees passes without a positive hit, expect these odds to crater. Everything hinges on the May 15 deadline.
79¢ → 70¢ • Vol: $0.5M